Trending

Tucker Carlson Talks Nonsense About U.S. Invading Canada To Remove Trudeau

'What The Actual F**k?': Matt Damon Loses It Over Kimmel's 20th Anniversary Snub

My Husband Left Me At 60 To Have A Baby With A Younger Woman. Here's What It Taught Me.

Doctor Faces Jan. 6 Charges After 'Former Friend' Reports Him To FBI

Rep. Alexandria Ocasio-Cortez Slams Republican Who Urged Her To 'Educate' Herself

Fox News' Geraldo Rivera Grilled Matt Gaetz On 'Torturing' McCarthy And It Got Frosty

Colbert Reveals 'Ominous' Sign Trump's About To Step Out On His Biggest Fans

Deborah Norville Reveals The Unexpected Big Break She Got From A U.S. President

Jimmy Kimmel Gets Roasted By Certified TV Legend In Anniversary Opener

Wanda Sykes Taunts Trump Facebook Return With A Jennifer Coolidge Impression

The 5-Minute Habits That Help Sleep Experts Fall Asleep Faster

Djokovic's Dad To Stay Away From Australian Open Semifinal After Russian Flag Controversy

Mylan Inc

Mylan Settles With Feds For $465 Million Over EpiPen Controversy

By Reuters, Reuters

Mylan Settles With Feds For $465 Million Over EpiPen Controversy

The company was accused of overcharging the government for EpiPens.
By Nate Raymond, Reuters

Drugmaker Mylan Gets Tax Boost From Refined Coal

By Reuters, Reuters

Drugmaker Mylan Gets Tax Boost From Refined Coal

Refined coal has quietly generated hundreds of millions of dollars of tax credits for the company over the last six years.
By Michael Erman, Reuters

Mylan May Have Overcharged U.S. For EpiPen By $1.27 Billion

By Reuters, Reuters

Mylan May Have Overcharged U.S. For EpiPen By $1.27 Billion

The amount is nearly three times a proposed settlement that the company announced in October.
By Michael Erman, Reuters

FDA Warns Mylan Over Quality Concerns At India Facility

By Reuters, Reuters

FDA Warns Mylan Over Quality Concerns At India Facility

Violations included a failure to “thoroughly investigate” unexplained discrepancies in drug batches and “missing, deleted, and lost data."
By Natalie Grover, Reuters

Mylan Hit With New Class Action Lawsuit Over EpiPen Pricing

By Reuters, Reuters

Mylan Hit With New Class Action Lawsuit Over EpiPen Pricing

The company came under fire last year after prices for its allergy devices shot up.
By Brendan Pierson, Reuters